148 related articles for article (PubMed ID: 19875048)
1. Targeting aldehyde dehydrogenase: a potential approach for cell labeling.
Vaidyanathan G; Song H; Affleck D; McDougald DL; Storms RW; Zalutsky MR; Chin BB
Nucl Med Biol; 2009 Nov; 36(8):919-29. PubMed ID: 19875048
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and preliminary evaluation of n.c.a. iodoquine: a novel radiotracer with high uptake in cells with high ALDH1 expression.
Chin BB; Hjelemand A; Rich J; Song H; Lascola C; Storms R; McLendon R; Reiman R; Greer KL; Metzler SD; McDougald D; Dai D; Vaidyanathan G
Curr Radiopharm; 2012 Jan; 5(1):47-58. PubMed ID: 21864242
[TBL] [Abstract][Full Text] [Related]
3. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer.
Magni M; Shammah S; Schiró R; Mellado W; Dalla-Favera R; Gianni AM
Blood; 1996 Feb; 87(3):1097-103. PubMed ID: 8562935
[TBL] [Abstract][Full Text] [Related]
4. Novel competitive irreversible inhibitors of aldehyde dehydrogenase (ALDH1): restoration of chemosensitivity of L1210 cells overexpressing ALDH1 and induction of apoptosis in BAF(3) cells overexpressing bcl(2).
Quash G; Fournet G; Chantepie J; Gore J; Ardiet C; Ardail D; Michal Y; Reichert U
Biochem Pharmacol; 2002 Oct; 64(8):1279-92. PubMed ID: 12234608
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells.
Russo JE; Hilton J
Cancer Res; 1988 Jun; 48(11):2963-8. PubMed ID: 3365687
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 1A1 in stem cells and cancer.
Tomita H; Tanaka K; Tanaka T; Hara A
Oncotarget; 2016 Mar; 7(10):11018-32. PubMed ID: 26783961
[TBL] [Abstract][Full Text] [Related]
7. Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases.
Moore SA; Baker HM; Blythe TJ; Kitson KE; Kitson TM; Baker EN
Structure; 1998 Dec; 6(12):1541-51. PubMed ID: 9862807
[TBL] [Abstract][Full Text] [Related]
8. Rat liver constitutive and phenobarbital-inducible cytosolic aldehyde dehydrogenases are highly homologous proteins that function as distinct isozymes.
Kathmann EC; Naylor S; Lipsky JJ
Biochemistry; 2000 Sep; 39(36):11170-6. PubMed ID: 10998257
[TBL] [Abstract][Full Text] [Related]
9. Characterization of ascites-derived aldehyde dehydrogenase-positive ovarian cancer stem cells isolated from Leghorn chickens.
Tiwari A; Hadley JA; Ramachandran R
Poult Sci; 2020 Apr; 99(4):2203-2214. PubMed ID: 32241506
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
Tsukamoto N; Chen J; Yoshida A
Blood Cells Mol Dis; 1998 Jun; 24(2):231-8. PubMed ID: 9714700
[TBL] [Abstract][Full Text] [Related]
11. Substrate specificity of human and yeast aldehyde dehydrogenases.
Wang MF; Han CL; Yin SJ
Chem Biol Interact; 2009 Mar; 178(1-3):36-9. PubMed ID: 18983993
[TBL] [Abstract][Full Text] [Related]
12. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
Kim D; Choi BH; Ryoo IG; Kwak MK
Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
[TBL] [Abstract][Full Text] [Related]
13. Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.
Hilton J
Cancer Res; 1984 Nov; 44(11):5156-60. PubMed ID: 6488175
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance.
Honoki K; Fujii H; Kubo A; Kido A; Mori T; Tanaka Y; Tsujiuchi T
Oncol Rep; 2010 Aug; 24(2):501-5. PubMed ID: 20596639
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of two closely related mouse aldehyde dehydrogenase genes: identification of a role for Aldh1, but not Aldh-pb, in the biosynthesis of retinoic acid.
Hsu LC; Chang WC; Hoffmann I; Duester G
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):387-95. PubMed ID: 10191271
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes.
Klyosov AA
Biochemistry; 1996 Apr; 35(14):4457-67. PubMed ID: 8605195
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
[TBL] [Abstract][Full Text] [Related]
18. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
[TBL] [Abstract][Full Text] [Related]
19. Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells.
Townsend AJ; Leone-Kabler S; Haynes RL; Wu Y; Szweda L; Bunting KD
Chem Biol Interact; 2001 Jan; 130-132(1-3):261-73. PubMed ID: 11306050
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
